Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-03-03 @ 2:58 PM
Study NCT ID:
NCT00620620
Status:
COMPLETED
Last Update Posted:
2017-03-14
First Post:
2008-02-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Staccato Zaleplon Single Dose Pharmacokinetics
Sponsor:
Alexza Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AMDC-007-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None